113 related articles for article (PubMed ID: 19596972)
1. Circulating hTERT DNA in early breast cancer.
Divella R; Tommasi S; Lacalamita R; Daniele A; Abbate I; Garrisi VM; Savino E; Coviello M; Rubini V; Simone G; Paradiso A; Quaranta M
Anticancer Res; 2009 Jul; 29(7):2845-9. PubMed ID: 19596972
[TBL] [Abstract][Full Text] [Related]
2. Expression of human telomerase reverse transcriptase gene and protein, and of estrogen and progesterone receptors, in breast tumors: preliminary data from neo-adjuvant chemotherapy.
Kammori M; Izumiyama N; Hashimoto M; Nakamura K; Okano T; Kurabayashi R; Naoki H; Honma N; Ogawa T; Kaminishi M; Takubo K
Int J Oncol; 2005 Nov; 27(5):1257-63. PubMed ID: 16211220
[TBL] [Abstract][Full Text] [Related]
3. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.
Novakovic S; Hocevar M; Zgajnar J; Besic N; Stegel V
Oncol Rep; 2004 Jan; 11(1):245-52. PubMed ID: 14654933
[TBL] [Abstract][Full Text] [Related]
4. A diagnostic evaluation of serum human telomerase reverse transcriptase mRNA as a novel tumor marker for gynecologic malignancies.
Miura N; Kanamori Y; Takahashi M; Sato R; Tsukamoto T; Takahashi S; Harada T; Sano A; Shomori K; Harada T; Kigawa J; Ito H; Terakawa N; Hasegawa J; Shiota G
Oncol Rep; 2007 Mar; 17(3):541-8. PubMed ID: 17273731
[TBL] [Abstract][Full Text] [Related]
5. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
Shen C; Hu L; Xia L; Li Y
Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
[TBL] [Abstract][Full Text] [Related]
6. HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR.
Mansfield L; Subramanian A; Devalia H; Jiang W; Newbold RF; Mokbel K
Anticancer Res; 2007; 27(4B):2265-8. PubMed ID: 17695512
[TBL] [Abstract][Full Text] [Related]
7. The hTERT mRNA in plasma samples of early breast cancer patients, non-cancer patients and healthy individuals.
Perhavec A; Cerkovnik P; Novakovic S; Zgajnar J
Neoplasma; 2008; 55(6):549-54. PubMed ID: 18999886
[TBL] [Abstract][Full Text] [Related]
8. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
9. Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease.
Terrin L; Rampazzo E; Pucciarelli S; Agostini M; Bertorelle R; Esposito G; DelBianco P; Nitti D; De Rossi A
Clin Cancer Res; 2008 Nov; 14(22):7444-51. PubMed ID: 19010861
[TBL] [Abstract][Full Text] [Related]
10. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
11. Real-time quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer.
Dasí F; Martínez-Rodes P; March JA; Santamaría J; Martínez-Javaloyas JM; Gil M; Aliño SF
Ann N Y Acad Sci; 2006 Sep; 1075():204-10. PubMed ID: 17108213
[TBL] [Abstract][Full Text] [Related]
12. Quantification of free circulating DNA as a diagnostic marker in lung cancer.
Sozzi G; Conte D; Leon M; Ciricione R; Roz L; Ratcliffe C; Roz E; Cirenei N; Bellomi M; Pelosi G; Pierotti MA; Pastorino U
J Clin Oncol; 2003 Nov; 21(21):3902-8. PubMed ID: 14507943
[TBL] [Abstract][Full Text] [Related]
13. Positive regulation of human telomerase reverse transcriptase gene expression and telomerase activity by DNA methylation in pancreatic cancer.
Kumari A; Srinivasan R; Vasishta RK; Wig JD
Ann Surg Oncol; 2009 Apr; 16(4):1051-9. PubMed ID: 19194757
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients.
Huang ZH; Li LH; Hua D
Cancer Lett; 2006 Nov; 243(1):64-70. PubMed ID: 16412565
[TBL] [Abstract][Full Text] [Related]
15. Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer.
Tani N; Ichikawa D; Ikoma D; Tomita H; Sai S; Ikoma H; Okamoto K; Ochiai T; Ueda Y; Otsuji E; Yamagishi H; Miura N; Shiota G
Anticancer Res; 2007; 27(2):1207-12. PubMed ID: 17465264
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer.
Altimari A; Grigioni AD; Benedettini E; Gabusi E; Schiavina R; Martinelli A; Morselli-Labate AM; Martorana G; Grigioni WF; Fiorentino M
Am J Clin Pathol; 2008 May; 129(5):756-62. PubMed ID: 18426736
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study on the alternative splicing pattern of human telomerase reverse transcriptase gene during gastric carcinogenesis].
Wang YC; Xu JH; Geng X; Zhang WM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):151-5. PubMed ID: 19350505
[TBL] [Abstract][Full Text] [Related]
19. PAI-1, t-PA and circulating hTERT DNA as related to virus infection in liver carcinogenesis.
Divella R; Lacalamita R; Tommasi S; Coviello M; Daniele A; Garrisi VM; Abbate I; Simone G; Gadaleta C; Paradiso A; Quaranta M
Anticancer Res; 2008; 28(1A):223-8. PubMed ID: 18383849
[TBL] [Abstract][Full Text] [Related]
20. Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease.
Zanetti-Dällenbach R; Wight E; Fan AX; Lapaire O; Hahn S; Holzgreve W; Zhong XY
Anticancer Res; 2008; 28(2A):921-5. PubMed ID: 18507037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
